Xeris Pharmaceuticals Inc (XERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Sales | 263 | 0 | 170 | 565 | 0 |
| Cost of Goods | 42 | N/A | 0 | 4 | N/A |
| Gross Profit | 221 | N/A | 170 | 561 | N/A |
| Operating Expenses | 11,993 | 0 | 7,742 | 5,764 | 0 |
| Operating Income | -11,730 | N/A | -7,572 | -5,199 | N/A |
| Interest Expense | 191 | 0 | 0 | 1 | 0 |
| Other Income | 14 | 0 | 45 | -32 | 0 |
| Pre-tax Income | -11,907 | 0 | -7,527 | -5,232 | 0 |
| Net Income Continuous | -11,907 | N/A | -7,527 | -5,232 | N/A |
| Net Income | $-11,907 | $N/A | $-7,527 | $-5,232 | $N/A |
| EPS Basic Total Ops | -5.49 | N/A | -3.72 | -2.59 | N/A |
| EPS Basic Continuous Ops | -5.49 | N/A | -3.72 | -2.59 | N/A |
| EPS Diluted Total Ops | -5.49 | N/A | -3.72 | -2.59 | N/A |
| EPS Diluted Continuous Ops | -5.49 | N/A | -3.72 | -2.59 | N/A |
| EBITDA(a) | $-11,627 | $N/A | $-7,520 | $-5,199 | $N/A |